Good morning :)
Place Order
Add to Watchlist

Rainbow Children's Medicare Ltd

RAINBOW Share Price

1,599.400.84% (+13.30)
High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP

With a market cap of ₹16,242 cr, stock is ranked 401

Stock is 2.48x as volatile as Nifty

RAINBOW Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is overpriced but is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

With a market cap of ₹16,242 cr, stock is ranked 401

Stock is 2.48x as volatile as Nifty

RAINBOW Performance & Key Metrics

RAINBOW Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
66.7211.010.19%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
37.156.590.82%

RAINBOW Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
100%
Analysts have suggested that investors can buy this stock

from 10 analysts

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

RAINBOW Company Profile

Rainbow Children’s Medicare is engaged in the business of rendering medical and healthcare services. The Company is a multi-specialty pediatric, and obstetrics and gynecology hospitals.

Investor Presentation

View older View older 

May 24, 2025

PDF
View Older Presentations

RAINBOW Similar Stocks (Peers)

Compare with peers Compare with peers 

RAINBOW Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
117.30
117.30
1Y Return
41.45%
41.45%
Buy Reco %
75.00
75.00
PE Ratio
75.11
75.11
1Y Return
21.34%
21.34%
Buy Reco %
89.66
89.66
PE Ratio
78.70
78.70
1Y Return
71.48%
71.48%
Buy Reco %
92.86
92.86
PE Ratio
51.70
51.70
1Y Return
61.99%
61.99%
Buy Reco %
77.78
77.78
PE Ratio
66.09
66.09
1Y Return
6.85%
6.85%
Buy Reco %
71.43
71.43
Compare with Peers

RAINBOW Sentiment Analysis

RAINBOW Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

RAINBOW Stock Summary · May 2025

In Q4 FY25, the company achieved an 8.5% revenue increase, driven by a strong performance in the mother care segment, despite facing operational challenges, particularly in international markets where healthcare permit issues impacted revenue. While the pediatric services segment struggled, management remains optimistic about future growth, targeting a 15-16% increase in the coming quarters, supported by robust cash generation and a healthy balance sheet with cash reserves nearing INR 700 crores. The expansion of hospital capacity, including the addition of 250 new beds, is expected to enhance operational efficiency and stabilize performance. Additionally, the IVF segment is rapidly growing, although it currently contributes modestly to overall revenue, highlighting the need for diversification. Overall, the company is focused on maintaining EBITDA margins above 25% while navigating the complexities of scaling its pediatric services.

RAINBOW Stock Growth Drivers
RAINBOW Stock Growth Drivers
7
  • Successful Operational Milestones

    The company has achieved significant operational milestones, including the successful completion of its first pediatric

  • Strong Financial Performance

    The company reported robust financial results, with operating revenue for Q4 FY '25 reaching INR370.1

RAINBOW Stock Challenges
RAINBOW Stock Challenges
5
  • Decline in International Revenue

    The company has experienced a significant decline in international revenue, which decreased from INR 44

  • Operational Performance Challenges

    In the fourth quarter, the company reported modest operational performance compared to the stronger second

RAINBOW Forecast

RAINBOW Forecasts

Price

Revenue

Earnings

RAINBOW

RAINBOW

Income

Balance Sheet

Cash Flow

RAINBOW Income Statement

RAINBOW Income Statement

Industry refers to the sub-sector this company belongs to.
Higher than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 16.51%, vs industry avg of 12.84%

Increasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 1.71% to 1.98%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 34.29%, vs industry avg of 41.11%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue332.38411.43551.14729.74660.31992.701,204.441,333.961,566.881,566.87
Raw Materialssubtract51.6259.9980.21105.31103.26194.73158.28165.28194.921,025.98
Power & Fuel Costsubtract8.279.3312.3514.8613.8416.8121.2326.6127.72
Employee Costsubtract69.2288.2485.74108.97102.09116.07144.06176.17206.37
Selling & Administrative Expensessubtract35.5546.36163.42216.79202.80266.74350.68395.99470.02
Operating & Other expensessubtract101.69128.5149.6272.7762.9171.5799.76100.49122.59
Depreciation/Amortizationsubtract21.8928.0860.3269.4173.3483.2690.27112.08138.44138.43
Interest & Other Itemssubtract2.904.2741.9648.2646.3756.1758.3962.5376.8172.45
Taxes & Other Itemssubtract9.9010.3912.9337.6315.6849.0870.9477.8286.5886.58
EPS4.224.475.076.344.5515.2021.5621.3823.9823.97
DPS0.310.500.501.000.002.003.003.003.003.00
Payout ratio0.070.110.100.160.000.130.140.140.130.13

RAINBOW Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2025FY 2025

Annual report

PDF

Investor Presentation

May 24PDF
Feb 9PDF
Oct 27PDF
FY 2024FY 2024

Annual report

PDF

Investor Presentation

Aug 7PDF
FY 2023FY 2023

Annual report

PDF

Investor Presentation

May 14PDF
Feb 9PDF
Nov 3PDF
+2 more
FY 2022FY 2022

Annual report

PDF

Investor Presentation

May 27PDF
 

RAINBOW Stock Peers

RAINBOW Past Performance & Peer Comparison

RAINBOW Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Rainbow Children's Medicare Ltd66.7211.010.19%
Max Healthcare Institute Ltd117.3015.010.12%
Apollo Hospitals Enterprise Ltd75.1114.840.37%
Fortis Healthcare Ltd78.707.120.12%

RAINBOW Stock Price Comparison

Compare RAINBOW with any stock or ETF
Compare RAINBOW with any stock or ETF
RAINBOW
Loading...

RAINBOW Holdings

RAINBOW Shareholdings

RAINBOW Promoter Holdings Trend

RAINBOW Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

RAINBOW Institutional Holdings Trend

RAINBOW Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has decreased by 1.42%

Tickertape Separator

RAINBOW Shareholding Pattern

RAINBOW Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding49.85%11.47%3.84%23.69%11.14%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

RAINBOW Shareholding History

RAINBOW Shareholding History

Dec '23MarJunSepDec '24Mar11.19%10.54%9.80%9.71%10.11%11.47%

Mutual Funds Invested in RAINBOW

Mutual Funds Invested in RAINBOW

No mutual funds holding trends are available

Top 5 Mutual Funds holding Rainbow Children's Medicare Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
1.3271%1.32%0.07%54/83 (-2)
0.8697%1.27%0.24%14/95 (+4)
0.8253%1.13%-0.02%51/65 (-2)

Compare 3-month MF holding change on Screener

RAINBOW Insider Trades & Bulk Stock Deals

RAINBOW Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing RAINBOW stock

smallcases containing RAINBOW stock

Looks like this stock is not in any smallcase yet.

RAINBOW Events

RAINBOW Events

RAINBOW Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

RAINBOW Dividend Trend

No dividend trend available

RAINBOW Upcoming Dividends

RAINBOW Upcoming Dividends

No upcoming dividends are available

RAINBOW Past Dividends

RAINBOW Past Dividends

Cash Dividend

Ex DateEx DateJun 27, 2025

Final
Final | Div/Share: ₹3.00

Dividend/Share

3.00

Ex DateEx Date

Jun 27, 2025

Cash Dividend

Ex DateEx DateJul 23, 2024

Final
Final | Div/Share: ₹3.00

Dividend/Share

3.00

Ex DateEx Date

Jul 23, 2024

Cash Dividend

Ex DateEx DateJun 22, 2023

Final
Final | Div/Share: ₹3.00

Dividend/Share

3.00

Ex DateEx Date

Jun 22, 2023

Cash Dividend

Ex DateEx DateSep 7, 2022

Final
Final | Div/Share: ₹2.00

Dividend/Share

2.00

Ex DateEx Date

Sep 7, 2022

RAINBOW Stock News & Opinions

RAINBOW Stock News & Opinions

Corporate
Rainbow Childrens Medicare to hold AGM

Rainbow Childrens Medicare announced that the 27th Annual General Meeting(AGM) of the company will be held on 5 July 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Rainbow Children's Medicare consolidated net profit rises 10.54% in the March 2025 quarter

Net profit of Rainbow Children's Medicare rose 10.54% to Rs 56.34 crore in the quarter ended March 2025 as against Rs 50.97 crore during the previous quarter ended March 2024. Sales rose 8.50% to Rs 370.11 crore in the quarter ended March 2025 as against Rs 341.10 crore during the previous quarter ended March 2024. For the full year,net profit rose 12.18% to Rs 243.42 crore in the year ended March 2025 as against Rs 217.00 crore during the previous year ended March 2024. Sales rose 16.88% to Rs 1515.87 crore in the year ended March 2025 as against Rs 1296.90 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales370.11341.10 9 1515.871296.90 17 OPM %31.0030.94 -32.3233.07 - PBDT111.13101.47 10 468.44406.90 15 PBT76.9769.17 11 330.00294.81 12 NP56.3450.97 11 243.42217.00 12 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Board of Rainbow Childrens Medicare recommends final dividend

Rainbow Childrens Medicare announced that the Board of Directors of the Company at its meeting held on 24 May 2025, inter alia, have recommended the final dividend of Rs 3 per equity Share (i.e. 30%) , subject to the approval of the shareholders.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Rainbow Childrens Medicare to declare Quarterly Results

Rainbow Childrens Medicare will hold a meeting of the Board of Directors of the Company on 24 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Spotlight
Volumes spurt at Rainbow Childrens Medicare Ltd counter

Castrol India Ltd, Triveni Engineering and Industries Ltd, Laurus Labs Ltd, Aurobindo Pharma Ltd are among the other stocks to see a surge in volumes on NSE today, 04 April 2025.Rainbow Childrens Medicare Ltd registered volume of 15.86 lakh shares by 14:14 IST on NSE, a 5.97 fold spurt over two-week average daily volume of 2.66 lakh shares. The stock rose 2.67% to Rs.1,410.40. Volumes stood at 51271 shares in the last session.Castrol India Ltd notched up volume of 196.67 lakh shares by 14:14 IST on NSE, a 4.49 fold spurt over two-week average daily volume of 43.78 lakh shares. The stock rose 0.60% to Rs.202.15. Volumes stood at 52.53 lakh shares in the last session.Triveni Engineering and Industries Ltd notched up volume of 12.53 lakh shares by 14:14 IST on NSE, a 3.98 fold spurt over two-week average daily volume of 3.15 lakh shares. The stock slipped 0.59% to Rs.378.70. Volumes stood at 3.58 lakh shares in the last session.Laurus Labs Ltd notched up volume of 63.36 lakh shares by 14:14 IST on NSE, a 3.87 fold spurt over two-week average daily volume of 16.39 lakh shares. The stock slipped 7.38% to Rs.574.85. Volumes stood at 37.44 lakh shares in the last session.Aurobindo Pharma Ltd notched up volume of 64.83 lakh shares by 14:14 IST on NSE, a 3.77 fold spurt over two-week average daily volume of 17.21 lakh shares. The stock slipped 6.08% to Rs.1,104.85. Volumes stood at 75.02 lakh shares in the last session.Powered by Capital Market - Live

3 months agoCapital Market - Live
Spotlight
Volumes spurt at Rainbow Childrens Medicare Ltd counter

Finolex Industries Ltd, Sun Pharma Advanced Research Company Ltd, Bajaj Finserv Ltd, Finolex Cables Ltd are among the other stocks to see a surge in volumes on BSE today, 24 March 2025.Rainbow Childrens Medicare Ltd notched up volume of 5.03 lakh shares by 10:48 IST on BSE, a 74.76 fold spurt over two-week average daily volume of 6733 shares. The stock rose 1.59% to Rs.1,322.70. Volumes stood at 8135 shares in the last session.Finolex Industries Ltd registered volume of 5.35 lakh shares by 10:48 IST on BSE, a 7.07 fold spurt over two-week average daily volume of 75680 shares. The stock rose 11.14% to Rs.193.50. Volumes stood at 72661 shares in the last session.Sun Pharma Advanced Research Company Ltd recorded volume of 14.8 lakh shares by 10:48 IST on BSE, a 3.61 times surge over two-week average daily volume of 4.09 lakh shares. The stock gained 1.18% to Rs.149.50. Volumes stood at 12.66 lakh shares in the last session.Bajaj Finserv Ltd saw volume of 1.44 lakh shares by 10:48 IST on BSE, a 3.35 fold spurt over two-week average daily volume of 43121 shares. The stock increased 1.97% to Rs.1,882.00. Volumes stood at 47109 shares in the last session.Finolex Cables Ltd saw volume of 1.06 lakh shares by 10:48 IST on BSE, a 2.39 fold spurt over two-week average daily volume of 44151 shares. The stock increased 12.08% to Rs.940.15. Volumes stood at 43016 shares in the last session.Powered by Capital Market - Live

3 months agoCapital Market - Live
Spotlight
Rainbow Medicare Q3 PAT jumps 11% YoY; ARPOB at Rs 53,404

Revenue from operations jumped 18.5% to Rs 398.08 crore in the quarter ended 31 December 2024. Total expenses rose by 22% YoY to Rs 317.03 crore in the third quarter. Cost of materials consumed stood at Rs 53.73 crore (up 25.8% YoY), employee benefit expense was at Rs 49.31 crore (up 13.5% YoY) and finance cost stood at Rs 18.07 crore (up 26.7% YoY) during the period under review. Profit before tax for the quarter stood at Rs 94.33 crore, up 11.3% from Rs 84.77 crore in the same quarter last year. For Q3 FY25, EBITDA grew 13.8% YoY to Rs 134.36 crore and EBITDA margin reduced to 33.8% from 35.1% posted in Q3 FY24. For the December 2024 quarter, capacity beds were at 1,935 units (up 17% YoY), operational bed count was 1,523 units (up 18% YoY) and occupancy rate was 53.2% (up 244 bps YoY). Average revenue per occupied bed (ARPOB) was Rs 53,404 (down 4% YoY) and average length of stay (ALOS) was 2.91 days (up 11% YoY) during the period under review. On the operational front, the regional hub hospital in Rajahmundry, which has around 100 beds, is nearing completion and is expected to commence operations by Q1 FY26. Rainbow Children's Hospital continues to maintain a robust balance sheet with cash, cash equivalents, fixed deposits, and mutual fund investments totaling Rs 6,669 million as of 31 December 2024. These funds will support our ongoing capital expenditure merger and acquisition plans. With our current cash and anticipated internal accruals in coming quarters, we are well-positioned to complete all planned capital expenditures using internal resources and balance IPO funds. During the quarter, the company had invested Rs 218.3 million in capital expenditures towards expanding and enhancing our services at existing hospitals Dr. Ramesh Kancharla, chairman & managing director, said, 'I'm pleased to share that we had a strong performance this quarter. With a network of over 2,000 beds, including managed facilities, we strike the perfect balance between established and new hospitals. Our focus is on boosting occupancy, optimizing operations, and providing exceptional experiences for our patients. Looking ahead, we're confident in our continued growth and success in the coming quarters.' Rainbow Children's Medicare is a multi-specialty pediatric, obstetrics and gynecology hospital chain in India, operating 19 hospitals and 5 clinics in 6 cities with a total bed capacity of 1,935 beds. The scrip slipped 2.60% to Rs 1,347.05 on the BSE. Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Rainbow Children's Medicare consolidated net profit rises 10.56% in the December 2024 quarter

Net profit of Rainbow Children's Medicare rose 10.56% to Rs 68.69 crore in the quarter ended December 2024 as against Rs 62.13 crore during the previous quarter ended December 2023. Sales rose 18.49% to Rs 398.08 crore in the quarter ended December 2024 as against Rs 335.96 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales398.08335.96 18 OPM %33.7535.15 - PBDT129.56112.43 15 PBT94.3384.77 11 NP68.6962.13 11 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Rainbow Childrens Medicare to announce Quarterly Result

Rainbow Childrens Medicare will hold a meeting of the Board of Directors of the Company on 9 February 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live
Spotlight
Rainbow Medicare gains after Q2 PAT climbs 25% YoY; ARPOB at Rs 49,770

Total expenses rose by 26.69% YoY to Rs 323.38 crore in the second quarter, primarily due to higher cost of materials consumed (up 22.32% YoY), employee benefit expense (up 31.94% YoY), higher finance cost (up 35.78% YoY) and higher professional fees to doctor (up 19.80% YoY). Profit before tax for the quarter stood at Rs 105.35 crore, up by 23.57% from Rs 85.25 crore in same quarter last year. For Q2 FY25, EBITDA grew 25.11% YoY to Rs 147.08 crore and EBITDA margin reduced to 35.2% from 35.3% posted in Q2 FY24. For the September 2024 quarter, capacity beds were at 1,935 units (up 16.9% YoY), operational bed count was 1,523 units (up 18.1% YoY) and occupancy rate was 59.9% (up 844 bps YoY). Average revenue per occupied bed (ARPOB) was Rs 49,770 (down 8.7% YoY) and average length of stay (ALOS) was 2.94 days (up 12.6% YoY) during the period under review. On the operational front, the company has signed a lease deed, for a brownfield spoke hospital to accommodate 90-beds in a rapidly growing micro market of Electronic City, Bengaluru and expect the hospital to commence operations, post interior works, by Q3 FY26. This will further strengthen Rainbow's hub and spoke model in Bengaluru. The firm continues to maintain a robust balance sheet, with cash, cash equivalents, fixed deposits, and mutual fund investments totaling Rs 5,814 million as of 30 September 2024. These funds will support its ongoing capital expenditure plans. With its current cash and anticipated internal accruals in the coming quarters, it is well-positioned to complete all planned capital expenditures using internal resources and the balance of IPO funds. During the quarter, the company had invested Rs 234 million in capital expenditures towards expanding and enhancing our services at existing hospitals. Dr. Ramesh Kancharla, chairman & managing director, said, 'I am delighted to share that we have delivered a strong performance this quarter led by robust volume growth across all hospitals. We currently have 2000+ beds, including the managed beds, with a right mix of matured and new beds. Our focus remains to drive occupancies and optimize operations across the group along with customer delight. We are confident in our ability to maintain the growth momentum in the upcoming quarters.' Rainbow Children's Medicare is a multi-specialty pediatric, obstetrics and gynecology hospital chain in India, operating 19 hospitals and 4 clinics in 6 cities, with a total bed capacity of 1,935 beds. Powered by Capital Market - Live

8 months agoCapital Market - Live

Frequently asked questions

Frequently asked questions

  1. What is the share price of Rainbow Children's Medicare Ltd (RAINBOW) today?

    The share price of RAINBOW as on 4th July 2025 is ₹1599.40. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Rainbow Children's Medicare Ltd (RAINBOW) share?

    The past returns of Rainbow Children's Medicare Ltd (RAINBOW) share are
    • Past 1 week: 3.77%
    • Past 1 month: 13.12%
    • Past 3 months: 13.47%
    • Past 6 months: 0.71%
    • Past 1 year: 21.48%
    • Past 3 years: 239.47%
    • Past 5 years: 255.26%

  3. What are the peers or stocks similar to Rainbow Children's Medicare Ltd (RAINBOW)?
  4. What is the dividend yield % of Rainbow Children's Medicare Ltd (RAINBOW) share?

    The current dividend yield of Rainbow Children's Medicare Ltd (RAINBOW) is 0.19.

  5. What is the market cap of Rainbow Children's Medicare Ltd (RAINBOW) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Rainbow Children's Medicare Ltd (RAINBOW) is ₹16242.17 Cr as of 4th July 2025.

  6. What is the 52 week high and low of Rainbow Children's Medicare Ltd (RAINBOW) share?

    The 52-week high of Rainbow Children's Medicare Ltd (RAINBOW) is ₹1709.60 and the 52-week low is ₹1079.10.

  7. What is the PE and PB ratio of Rainbow Children's Medicare Ltd (RAINBOW) stock?

    The P/E (price-to-earnings) ratio of Rainbow Children's Medicare Ltd (RAINBOW) is 66.72. The P/B (price-to-book) ratio is 11.01.

  8. Which sector does Rainbow Children's Medicare Ltd (RAINBOW) belong to?

    Rainbow Children's Medicare Ltd (RAINBOW) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.

  9. How to buy Rainbow Children's Medicare Ltd (RAINBOW) shares?

    You can directly buy Rainbow Children's Medicare Ltd (RAINBOW) shares on Tickertape. Simply sign up, connect your demat account and place your order.